ArticleHemaSphere2021

Clinicopathologic Characteristics, Treatment, and Outcomes of Post-transplant Lymphoproliferative Disorders: A Single-institution Experience Using 2017 WHO Diagnostic Criteria.

Rebecca L King et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.